CeQur是一家创新医疗器械公司，2008年成立于瑞士，专注于为糖尿病患者提供餐时胰岛素解决方案。 2025年1月7日，CeQur宣布完成1.2亿美元融资（约8.78亿人民币）。这笔资金将用于推动公司的增长并加速商业扩张，同时继续增加和改善药房渠道对其设备的推广。

Switzerland-based CeQur has completed a $120m equity financing round to support the ongoing commercialisation efforts for its CeQur Simplicity insulin delivery device. The company stated that since ...

LUCERNE, Switzerland & MARLBOROUGH, Mass.--(BUSINESS WIRE)-- CeQur®, a medical device company committed to simplifying the lives of people with diabetes by revolutionizing insulin-delivery solutions, ...

Novel, discreet, and simple insulin-delivery system can replace need for mealtime injections for people with diabetes Largest fundraising to date for a privately held medtech company in Europe was led ...

LUCERNE, Switzerland & MARLBOROUGH, Mass.--(BUSINESS WIRE)--CeQur ®, a medical device company committed to simplifying the lives of people with diabetes by revolutionizing insulin-delivery solutions, ...

Marlborough insulin delivery company CeQur announced Tuesday it had raised $115 million in equity financing. The company said it will use the funds to advance commercial plans towards a limited market ...

LEXINGTON — A Swiss medical device company, CeQur Simplicity, plans to invest $20 million to begin manufacturing in Lexington County. The company is contracting with Flex, a global manufacturing firm ...